INHIBRX BIOSCIENCES, INC. (INBX) Operating income 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) annual operating income history from SEC filings — each fiscal year as reported.
-$135.0MFY2025 · since FY2023: -$219.2M → -$135.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$135.0M | +59.3% |
| FY2024 | -$331.4M | -51.2% |
| FY2023 | -$219.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating marginINBX Operating cash flowINBX Free cash flowINBX Capital expendituresINBX Return on equityINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Total liabilitiesINBX Shareholders’ equityINBX overview →